Example: tourism industry
Reference ID: 3306791 - Food and Drug …
of chickenpox or measles can occur in susceptible patients. (5.6) HIGHLIGHTS OF PRESCRIBING INFORMATION BREO ELLIPTA inhaler safely and effectively.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION - PI …
www.azpicentral.comHIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use SYMBICORT safely and effectively. See full prescribing information for SYMBICORT.
Prescribing Information - docs.boehringer …
docs.boehringer-ingelheim.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Maintenance Treatment of Chronic Obstructive Pulmonary Disease SPIRIVA RESPIMAT (tiotropium bromide) is indicated for the long- term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIOLTO RESPIMAT safely and effectively.
WARNINGS AND PRECAUTIONS----------------- - PI …
www.azpicentral.comHIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use BEVESPI AEROSPHERE safely and effectively.
History of known hypersensitivity to indacaterol ...
www.utibron.comfull prescribing information: contents* warning: asthma-related death 1 indications and usage 2 dosage and administration 3 dosage forms and strengths
Polypharmacy: Guidance for Prescribing - AWMSG
www.awmsg.orgPolypharmacy: Guidance for Prescribing Supplementary Guidance – BNF Sections to Target . July 2014
GUIDELINES FOR THE USE OF BENZODIAZEPINES …
www.benzos.une.edu1 GUIDELINES FOR THE USE OF BENZODIAZEPINES IN OFFICE PRACTICE IN THE STATE OF MAINE Introduction: This is an evidence based guideline for the use of benzodiazepines and related drugs in